Drug Shortage Report for WELLBUTRIN XL
Report ID | 161368 |
Drug Identification Number | 02275090 |
Brand name | WELLBUTRIN XL |
Common or Proper name | WELLBUTRIN XL |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
Strength(s) | 150MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 90s |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-06-14 |
Estimated end date | 2022-09-15 |
Actual end date | 2021-08-30 |
Shortage status | Avoided shortage |
Updated date | 2022-08-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-08-31 | English | Compare |
v11 | 2022-08-25 | French | Compare |
v10 | 2022-08-25 | English | Compare |
v9 | 2022-08-03 | French | Compare |
v8 | 2022-08-03 | English | Compare |
v7 | 2022-07-20 | French | Compare |
v6 | 2022-07-20 | English | Compare |
v5 | 2022-06-15 | French | Compare |
v4 | 2022-06-15 | English | Compare |
v3 | 2022-05-26 | French | Compare |
v2 | 2022-05-26 | English | Compare |
v1 | 2022-05-26 | English | Compare |
Showing 1 to 12 of 12